Loomis, Sayles & Company’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-370,605
Closed -$7.22M 720
2019
Q1
$7.22M Buy
370,605
+36,973
+11% +$701K 0.01% 395
2018
Q4
$5.5M Sell
333,632
-1,243
-0.4% -$25K 0.01% 407
2018
Q3
$7.74M Buy
334,875
+9,613
+3% +$218K 0.02% 423
2018
Q2
$7.07M Sell
325,262
-781
-0.2% -$15.3K 0.01% 494
2018
Q1
$5.75M Sell
326,043
-2,338
-0.7% -$41.2K 0.01% 519
2017
Q4
$6.16M Sell
328,381
-416
-0.1% -$8.27K 0.01% 501
2017
Q3
$7.21M Sell
328,797
-45,849
-12% -$1.04M 0.02% 481
2017
Q2
$9.03M Sell
374,646
-3,378
-0.9% -$85.9K 0.02% 438
2017
Q1
$10.6M Buy
378,024
+190,139
+101% +$4.99M 0.03% 410
2016
Q4
$4.59M Sell
187,885
-128,002
-41% -$2.93M 0.01% 547
2016
Q3
$7.95M Sell
315,887
-650,722
-67% -$15.6M 0.02% 458
2016
Q2
$19.9M Buy
966,609
+112,336
+13% +$2.34M 0.05% 269
2016
Q1
$17.2M Sell
854,273
-232,670
-21% -$4.46M 0.05% 318
2015
Q4
$22M Sell
1,086,943
-188,394
-15% -$3.97M 0.06% 247
2015
Q3
$29.6M Sell
1,275,337
-2,404
-0.2% -$61.3K 0.09% 185
2015
Q2
$32.9M Buy
1,277,741
+1,830
+0.1% +$52K 0.09% 192
2015
Q1
$42.3M Sell
1,275,911
-30,615
-2% -$993K 0.12% 158
2014
Q4
$39.7M Buy
1,306,526
+197,488
+18% +$5.44M 0.11% 167
2014
Q3
$27M Sell
1,109,038
-53,242
-5% -$1.48M 0.08% 224
2014
Q2
$33.4M Sell
1,162,280
-37,072
-3% -$1.08M 0.09% 202
2014
Q1
$33.5M Sell
1,199,352
-40,338
-3% -$1.11M 0.09% 206
2013
Q4
$32.4M Sell
1,239,690
-10,237
-0.8% -$264K 0.1% 205
2013
Q3
$28.8M Sell
1,249,927
-19,004
-1% -$468K 0.09% 223
2013
Q2
$33.1K Buy
+1,268,931
New +$36.6M 0.12% 192

Other funds holding SBRA

Loomis, Sayles & Company's SBRA Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of Sabra Healthcare REIT (SBRA) in Q2 2019, closing a stake of 370,605 shares — an estimated $7.22M sold.

Loomis, Sayles & Company first reported a position in SBRA in Q2 2013 and held it in 24 quarters. The position peaked at $42.3M in Q1 2015. 309 funds tracked by Wall St. Rank hold SBRA as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining Sabra Healthcare REIT position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 370,605 Sabra Healthcare REIT shares in Q2 2019, an estimated $7.22M.
  • Loomis, Sayles & Company first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 24 quarters.
  • Loomis, Sayles & Company's Sabra Healthcare REIT position peaked at $42.3M in Q1 2015.
  • 309 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.